Syneos Health_rgb_r.jpg
Syneos Health Announces Secondary Offering of Common Stock
March 01, 2021 06:44 ET | Syneos Health, Inc.
MORRISVILLE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health_rgb_r.jpg
Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data
February 24, 2021 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C. and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Protocol First, Inc., a...
Syneos Health_rgb_r.jpg
Syneos Health Communications Bolsters Value, Access and Public Affairs Offerings with Key Senior Hires
February 23, 2021 09:51 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...
Syneos Health_rgb_r.jpg
Syneos Health Reports Fourth Quarter and Full Year 2020 Results
February 18, 2021 06:15 ET | Syneos Health, Inc.
Highlights GAAP revenue of $1,140.0 million for the three months ended December 31, 2020, representing a sequential increase of 3.7% compared to the three months ended September 30, 2020.Net...
Syneos Health_rgb_r.jpg
Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare
February 11, 2021 08:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, is pulsing a series of 2021 Health Trends –...
Syneos Health_rgb_r.jpg
Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021
January 26, 2021 18:37 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health_rgb_r.jpg
Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:15 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health Acquires Illingworth Research Group, a Leading Provider of Clinical Research Home Health Services
December 18, 2020 09:14 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of Illingworth...
Syneos Health_rgb_r.jpg
Syneos Health Completes Acquisition of Synteract
December 10, 2020 08:59 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the...
Syneos Health_rgb_r.jpg
Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event
December 07, 2020 17:18 ET | Syneos Health, Inc.
Unique Product Development Model Delivers Accelerated Growth Presentation Begins at 9:00 A.M. ET on Tuesday, December 8 MORRISVILLE, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Syneos Health®...